LOC402377 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.30909999507267E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.07959999828822E-08 |
Normal-vs-Stage2 |
1.676230E-03 |
Normal-vs-Stage3 |
1.3513000000076E-06 |
Normal-vs-Stage4 |
1.58251999999859E-05 |
Stage1-vs-Stage2 |
3.768800E-01 |
Stage1-vs-Stage3 |
7.865000E-01 |
Stage1-vs-Stage4 |
5.383400E-01 |
Stage2-vs-Stage3 |
2.840600E-01 |
Stage2-vs-Stage4 |
1.950250E-01 |
Stage3-vs-Stage4 |
6.081800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.00660000124498E-08 |
Normal-vs-AfricanAmerican |
1.16869958155519E-10 |
Normal-vs-Asian |
8.46620000000131E-05 |
Caucasian-vs-AfricanAmerican |
4.536000E-02 |
Caucasian-vs-Asian |
2.881200E-01 |
AfricanAmerican-vs-Asian |
4.796200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.02990005412806E-09 |
Normal-vs-Female |
6.986900E-04 |
Male-vs-Female |
1.631670E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.29729999964745E-07 |
Normal-vs-Extreme_Weight |
1.00379999867783E-08 |
Normal-vs-Obese |
1.61940999999777E-05 |
Normal-vs-Extreme_Obese |
6.617900E-04 |
Normal_Weight-vs-Extreme_Weight |
8.096600E-01 |
Normal_Weight-vs-Obese |
3.431800E-01 |
Normal_Weight-vs-Extreme_Obese |
6.920600E-01 |
Extreme_Weight-vs-Obese |
1.771250E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.974400E-01 |
Obese-vs-Extreme_Obese |
8.597600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.595100E-03 |
Normal-vs-Age(41-60Yrs) |
5.8060999996723E-07 |
Normal-vs-Age(61-80Yrs) |
1.394899973306E-09 |
Normal-vs-Age(81-100Yrs) |
4.12699999999822E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.911200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.118600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.193400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.411600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.325400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.75650000100447E-08 |
Normal-VS-Type2 PRCC |
5.10740000292387E-08 |
Normal-VS-KIRP CIMP |
1.951430E-01 |
Normal-VS-Unclassified PRCC |
2.410200E-04 |
Type1 PRCC-VS-Type2 PRCC |
6.827000E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.652300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
4.851600E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.262200E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.483000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.216600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.57979995751845E-09 |
Normal-vs-N1 |
1.647750E-04 |
Normal-vs-N2 |
1.542120E-03 |
N0-vs-N1 |
3.456800E-01 |
N0-vs-N2 |
6.714400E-01 |
N1-vs-N2 |
4.902200E-01 |
|
|